Mkts

Rigel Pharmaceuticals, Inc.

NASDAQ: RIGL
$42.92-0.81 (-1.85%)
As of Nov 17, 4:00 PM ET

Key statistics

Day range
42.1043.48
52-week range
24.9552.60
Today
Open43.43
Previous close42.92
Volume249.6K
Valuation
Market cap823.43M
P/E ratio2.56×
EPS (TTM)16.04
Income & risk
Dividend / yield—
Beta1.30
Avg volume275.4K
Discussion

RIGL News

Stories mentioning RIGL from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue58,81869,80269,462101,68553,33357,59655,30736,841
Cost of Goods Sold4,6065,9554,7534,5044,4095,7898,0262,807
Gross Profit54,21263,84764,70997,18148,92451,80747,28134,034
Operating Expenses
Research & Development11,6768,436
Sales General & Admin30,65129,99228,93629,25727,71529,52027,04328,047
Total Operating Expenses
Operating Income (Loss)11,88523,17028,42061,10312,77316,65514,056447.00
Interest Income1,2051,2431,094753.00591.00522.00425.00552.00
Interest Expense1,8941,8741,8531,9552,0602,029
Other Expense
Pretax Income11,65722,71427,62059,98211,51115,22212,421(1,030)
Tax Provision3,003(245,351)(280.00)369.0065.00881.000.000.00
Net Income (Loss)8,654268,06527,90059,61311,44614,34112,421(1,030)
Earnings Per Share (Basic)0.4714.901.553.330.640.820.71(0.06)
Earnings Per Share (Diluted)0.4414.231.463.280.630.810.70(0.06)
Weighted Average Shares Outstanding (Basic)18,41217,98718,03817,88517,80817,57917,60017,549
Weighted Average Shares Outstanding (Diluted)19,68618,84019,15618,16218,16917,68717,64817,549

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RIGL

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is a stock listed on the Nasdaq Stock Market under the ticker symbol RIGL. It last traded at $42.92 (Nov 17, 2026, 4:00 PM ET), down 1.9% on the day. That gives Rigel Pharmaceuticals a market capitalisation of $823.4M and a price-to-earnings ratio of 2.6.

Over the past 52 weeks RIGL has traded between $24.95 and $52.60.

Revenue for the quarter ended Mar 31, 2026 was $58.8M; net income $8.7M. Revenue was up 10.3% from $53.3M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$58.8M$8.7M14.7%
Dec 31, 2025$69.8M$268.1M384.0%
Sep 30, 2025$69.5M$27.9M40.2%
Jun 30, 2025$101.7M$59.6M58.6%

From Rigel Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…